TWI818223B - Peony extract for anti-inflammation, anti-allergy, anti-oxidation, anti-glycation and anti-wrinkle - Google Patents
Peony extract for anti-inflammation, anti-allergy, anti-oxidation, anti-glycation and anti-wrinkle Download PDFInfo
- Publication number
- TWI818223B TWI818223B TW110100913A TW110100913A TWI818223B TW I818223 B TWI818223 B TW I818223B TW 110100913 A TW110100913 A TW 110100913A TW 110100913 A TW110100913 A TW 110100913A TW I818223 B TWI818223 B TW I818223B
- Authority
- TW
- Taiwan
- Prior art keywords
- peony
- extract
- peony extract
- whole
- glycation
- Prior art date
Links
- 235000006484 Paeonia officinalis Nutrition 0.000 title claims abstract description 115
- 239000000284 extract Substances 0.000 title claims abstract description 86
- 230000001153 anti-wrinkle effect Effects 0.000 title claims abstract description 20
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 18
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 6
- 230000003064 anti-oxidating effect Effects 0.000 title abstract 2
- 244000170916 Paeonia officinalis Species 0.000 title 1
- 241000736199 Paeonia Species 0.000 claims abstract description 147
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 18
- 230000003078 antioxidant effect Effects 0.000 claims description 18
- 238000002791 soaking Methods 0.000 claims description 17
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 15
- 239000000287 crude extract Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 5
- 230000002829 reductive effect Effects 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 4
- 210000004927 skin cell Anatomy 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 230000004071 biological effect Effects 0.000 abstract description 19
- 229930003935 flavonoid Natural products 0.000 abstract description 9
- 235000017173 flavonoids Nutrition 0.000 abstract description 9
- 150000002215 flavonoids Chemical class 0.000 abstract description 9
- 235000021286 stilbenes Nutrition 0.000 abstract description 9
- 150000001629 stilbenes Chemical class 0.000 abstract description 9
- 229920001864 tannin Polymers 0.000 abstract description 9
- 235000018553 tannin Nutrition 0.000 abstract description 9
- 239000001648 tannin Substances 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 8
- 150000002989 phenols Chemical class 0.000 abstract description 7
- 150000003648 triterpenes Chemical class 0.000 abstract description 7
- -1 monoterpenoid glucosides Chemical class 0.000 abstract description 6
- 229930182478 glucoside Natural products 0.000 abstract description 5
- 229930003658 monoterpene Natural products 0.000 abstract description 5
- 238000000874 microwave-assisted extraction Methods 0.000 abstract description 3
- 238000002525 ultrasonication Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 53
- 230000000694 effects Effects 0.000 description 30
- 238000000605 extraction Methods 0.000 description 27
- 108010003272 Hyaluronate lyase Proteins 0.000 description 25
- 102000001974 Hyaluronidases Human genes 0.000 description 25
- 229960002773 hyaluronidase Drugs 0.000 description 25
- 229920002674 hyaluronan Polymers 0.000 description 18
- 239000007788 liquid Substances 0.000 description 18
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 16
- 229960003160 hyaluronic acid Drugs 0.000 description 16
- 102000000589 Interleukin-1 Human genes 0.000 description 13
- 108010002352 Interleukin-1 Proteins 0.000 description 13
- 230000004900 autophagic degradation Effects 0.000 description 12
- 102000053187 Glucuronidase Human genes 0.000 description 11
- 108010060309 Glucuronidase Proteins 0.000 description 11
- 238000000926 separation method Methods 0.000 description 11
- 230000032683 aging Effects 0.000 description 9
- 239000000084 colloidal system Substances 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 238000001962 electrophoresis Methods 0.000 description 8
- 239000002158 endotoxin Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 229920006008 lipopolysaccharide Polymers 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000006143 cell culture medium Substances 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 108010005774 beta-Galactosidase Proteins 0.000 description 6
- 230000000770 proinflammatory effect Effects 0.000 description 6
- 102000005936 beta-Galactosidase Human genes 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 4
- 229940030275 epigallocatechin gallate Drugs 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 230000036252 glycation Effects 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 210000003630 histaminocyte Anatomy 0.000 description 4
- 235000002577 monoterpenes Nutrition 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 230000009758 senescence Effects 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 210000004957 autophagosome Anatomy 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000028709 inflammatory response Effects 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000012474 protein marker Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 2
- 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 230000006020 chronic inflammation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- JWYAAAWHMYXKTC-UHFFFAOYSA-L disodium chloride formate Chemical compound [Cl-].[Na+].C(=O)[O-].[Na+] JWYAAAWHMYXKTC-UHFFFAOYSA-L 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 2
- 229940099552 hyaluronan Drugs 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- KDXHLJMVLXJXCW-UHFFFAOYSA-J alcian blue stain Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cu+2].[N-]1C(N=C2C3=CC(CSC(N(C)C)=[N+](C)C)=CC=C3C(N=C3C4=CC=C(CSC(N(C)C)=[N+](C)C)C=C4C(=N4)[N-]3)=N2)=C(C=C(CSC(N(C)C)=[N+](C)C)C=C2)C2=C1N=C1C2=CC(CSC(N(C)C)=[N+](C)C)=CC=C2C4=N1 KDXHLJMVLXJXCW-UHFFFAOYSA-J 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 108010067755 dinitrophenyl-bovine serum albumin Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本發明關於一種植物萃取物,特別關於一種用於製備抗發炎、抗敏、抗氧化、抗醣化及抗皺之組合物的植物萃取物。The present invention relates to a plant extract, in particular to a plant extract used for preparing anti-inflammatory, anti-allergic, antioxidant, anti-glycation and anti-wrinkle compositions.
隨著國民生活水準提升,現代人對於自己的儀容越來越重視,其中對抗皮膚衰老逐漸成為市場主旋律。人們對於促進細胞修復、抗皺、抗老相關產品的需求量大增。此外,現今健康產品知識相當普及,人們為避免因化學成分之化粧保養品傷害皮膚甚或沈積於體內,在保健食品與美容應用方面的產品,中草藥等天然物的應用受到重視,尤其將中草藥萃取物應用於化粧品中已成為全球趨勢,亦是近年國內化妝品及生技產業積極開發的重點。With the improvement of national living standards, modern people pay more and more attention to their appearance, and fighting skin aging has gradually become the main theme of the market. People's demand for products related to promoting cell repair, anti-wrinkle, and anti-aging has increased significantly. In addition, knowledge about health products is quite popular nowadays. In order to avoid cosmetics and skin care products with chemical ingredients from damaging the skin or even being deposited in the body, people attach great importance to the application of natural products such as health food and beauty products, Chinese herbal medicines, especially Chinese herbal extracts. Its application in cosmetics has become a global trend and has also been the focus of active development in the domestic cosmetics and biotechnology industries in recent years.
老化係人體一不可逆的狀態,當人體細胞經過多代分裂,會受到外界過度刺激導致生長停滯進而老化。許多研究文獻指出,老化與慢性發炎、氧化壓力及醣化息息相關。人體除了隨年齡增長而造成的老化之外,也會在環境諸多不利因子影響下加速或提前老化,諸如長期暴露於陽光下、飲食不均衡、組織受損、微生物感染、疲勞過度、生活壓力大等外源性的老化因子。Aging is an irreversible state of the human body. When human cells divide for many generations, they will be over-stimulated by the outside world, resulting in growth stagnation and aging. Many research literature points out that aging is closely related to chronic inflammation, oxidative stress and glycation. In addition to aging caused by age, the human body will also accelerate or prematurely age under the influence of many adverse environmental factors, such as long-term exposure to the sun, unbalanced diet, tissue damage, microbial infection, excessive fatigue, and high life pressure. and other exogenous aging factors.
其中,人體內的反應性氧族 (ROS),如超氧自由基 (‧O 2 -) 及過氧化氫 (H 2O 2),在含有游離金屬的環境下,會被轉變為氫氧自由基 (‧OH),其所具備的高活性對人體組織會造成最直接的傷害。過量的自由基累積除了會造成表皮、真皮結締組織中的脂質過氧化之外,亦會致使膠原蛋白質變性。已有研究指出,過氧化反應亦間接促使發炎相關基因的表現,從而導致慢性發炎。 Among them, the reactive oxygen species (ROS) in the human body, such as superoxide radicals (‧O 2 - ) and hydrogen peroxide (H 2 O 2 ), will be converted into hydrogen and oxygen free radicals in an environment containing free metals. (‧OH), its high activity will cause the most direct damage to human tissues. Excessive free radical accumulation will not only cause lipid peroxidation in the epidermis and dermal connective tissue, but also cause collagen protein denaturation. Studies have pointed out that peroxidation also indirectly promotes the expression of inflammation-related genes, leading to chronic inflammation.
此外,由於日常飲食中潛藏著許多高糖分食品,現代人習於外食易導致過度攝取醣類。多餘的醣類和體內的蛋白質結合後,破壞蛋白質原有的結構,其所產生的醣化終產物(Advanced glycation end-products, AGEs)堆積不僅使肌膚老化,造成鬆弛、皺紋、暗沉,亦可能會導致動脈硬化、糖尿病等疾病。In addition, because there are many high-sugar foods hidden in the daily diet, modern people's habit of eating out can easily lead to excessive intake of sugar. After excess sugar combines with proteins in the body, it destroys the original structure of the protein. The accumulation of advanced glycation end-products (AGEs) not only causes skin aging, causing sagging, wrinkles, and dullness, but may also Can cause arteriosclerosis, diabetes and other diseases.
除上述機制造成的老化現象外,人體組織內的玻尿酸亦會隨著年齡增加逐漸流失。玻尿酸又稱透明質酸、醣醛酸,外觀透明具有黏性,會吸引大量的鈉離子。超過 50% 人體所含的玻尿酸為細胞外間質的主要成分,在維持皮膚的含水量及彈性等功能方面扮演重要角色。每天有 1/3 的玻尿酸會被自體生成的酵素所降解,皮膚因此逐漸失去基本保濕的功能而形成空隙,最終導致肌膚失去彈力、光澤,鬆弛、老化皺紋因而產生。因此,如能抑制玻尿酸的分解,可預期達到改善皮膚鬆弛、減少皺紋等減緩老化的目的。In addition to the aging phenomenon caused by the above-mentioned mechanisms, hyaluronic acid in human tissues will also gradually lose with age. Hyaluronic acid, also known as hyaluronic acid and uronic acid, has a transparent and sticky appearance and attracts a large amount of sodium ions. More than 50% of hyaluronic acid contained in the human body is the main component of the extracellular matrix and plays an important role in maintaining skin's moisture content and elasticity. 1/3 of the hyaluronic acid will be degraded by self-generated enzymes every day. As a result, the skin gradually loses its basic moisturizing function and forms gaps. This eventually causes the skin to lose its elasticity and luster, causing sagging and aging wrinkles. Therefore, if the decomposition of hyaluronic acid can be inhibited, it can be expected to improve skin sagging, reduce wrinkles and slow down aging.
有鑑於此,亟需提出一種抗發炎、抗氧化、抗醣化以及抗皺等複數種生物活性的植物性物質,以期能提供化妝品組合物及/或食品添加物。In view of this, there is an urgent need to propose a plant-based substance with multiple biological activities such as anti-inflammation, antioxidant, anti-glycation, and anti-wrinkle, in order to provide cosmetic compositions and/or food additives.
本發明基於一未可預期之發現所完成,牡丹經水萃取之水萃萃取物,其具有單萜醣苷類(glucosides)、黃酮類(flavonoids)、單寧(tannins)、茋(stilbenes)、三萜類化合物(triterpenoids)、芍藥醇(paeonols)和酚類(phenols)等複數種具抗發炎、抗過敏、抗氧化、抗醣化或抗皺生物活性之成分。是以,本發明之一目的為提供一種牡丹萃取物,係以水浸泡牡丹全株萃取而得。The present invention is based on an unexpected discovery. The aqueous extract of peony extracted with water contains monoterpene glycosides (glucosides), flavonoids (flavonoids), tannins (tannins), stilbenes (stilbenes), and triterpenes. Terpenoids, paeonols and phenols are a variety of ingredients with anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle biological activities. Therefore, one object of the present invention is to provide a peony extract, which is obtained by soaking the whole peony plant in water.
較佳者,以連續式超音波震盪該水及該牡丹全株。Preferably, the water and the whole peony plant are vibrated with continuous ultrasonic waves.
較佳者,浸泡溫度為 50~80˚C。Preferably, the soaking temperature is 50~80˚C.
較佳者,浸泡時間為 5~60 分鐘。Preferably, the soaking time is 5 to 60 minutes.
較佳者,牡丹全株包含有牡丹花、牡丹莖葉及牡丹根皮。Preferably, the whole peony plant includes peony flowers, peony stems and leaves, and peony root bark.
較佳者,所述牡丹全株包含以下重量份數之原料:牡丹花38~45重量份、牡丹莖葉46~53重量份及牡丹根皮2~9重量份。Preferably, the whole peony plant contains the following raw materials in parts by weight: 38-45 parts by weight of peony flowers, 46-53 parts by weight of peony stems and leaves, and 2-9 parts by weight of peony root bark.
較佳者,牡丹萃取物為經減壓濃縮處理或冷凍乾燥處理精製而取得的萃取精緻物。Preferably, the peony extract is an extract refined by concentration under reduced pressure or freeze-drying.
依本發明再提出一種上述牡丹萃取物之製備方法,係包含:以水浸泡牡丹全株萃取而得。According to the present invention, a method for preparing the above-mentioned peony extract is further proposed, which includes: soaking the whole peony plant in water and extracting it.
較佳者,以連續式超音波震盪該水及該牡丹全株。Preferably, the water and the whole peony plant are vibrated with continuous ultrasonic waves.
較佳者,浸泡溫度為 50~80˚C。Preferably, the soaking temperature is 50~80˚C.
較佳者,浸泡時間為 5~60 分鐘。Preferably, the soaking time is 5 to 60 minutes.
較佳者,牡丹全株包含有牡丹花、牡丹莖葉及牡丹根皮。Preferably, the whole peony plant includes peony flowers, peony stems and leaves, and peony root bark.
較佳者,所述牡丹全株包含以下重量份數之原料:牡丹花38~45重量份、牡丹莖葉46~53重量份及牡丹根皮2~9重量份。Preferably, the whole peony plant contains the following raw materials in parts by weight: 38-45 parts by weight of peony flowers, 46-53 parts by weight of peony stems and leaves, and 2-9 parts by weight of peony root bark.
較佳者,製備方法更包括:經減壓濃縮處理或冷凍乾燥處理精製以水浸泡牡丹材料所得的粗萃取物。Preferably, the preparation method further includes: refining the crude extract obtained by soaking the peony material in water through vacuum concentration or freeze-drying.
依本發明,牡丹萃取物具有單萜醣苷類(glucosides)、黃酮類(flavonoids) 、單寧(tannins) 、茋(stilbenes) 、三萜類化合物(triterpenoids)、芍藥醇(paeonols)和酚類(phenols)等複數種具抗發炎、抗過敏、抗氧化、抗醣化或抗皺生物活性之成分。基於前述特性,牡丹萃取物可用於製備抗發炎、抗過敏、抗氧化、抗醣化或抗皺之組合物以用於化妝品組合物及/或食品添加物之用途,此組合物係以一有效劑量的牡丹萃取物投放至所需個體,以達抗發炎、抗過敏、抗氧化、抗醣化或抗皺之功效。According to the present invention, the peony extract contains monoterpene glycosides (glucosides), flavonoids (flavonoids), tannins (tannins), stilbenes (stilbenes), triterpenoids (triterpenoids), paeonols (paeonols) and phenols ( phenols) and many other ingredients with anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle biological activities. Based on the aforementioned properties, peony extract can be used to prepare anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle compositions for use in cosmetic compositions and/or food additives. This composition is formulated with an effective dose. Peony extract is administered to the desired individual to achieve anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle effects.
較佳者,抗發炎為抑制細胞促炎性細胞因子IL-1 (Proinflammatory cytokine Interleukin-1) 釋放之生物活性。Preferably, anti-inflammatory is a biological activity that inhibits the release of proinflammatory cytokine IL-1 (Proinflammatory cytokine Interleukin-1) from cells.
較佳者,抗過敏為抑制細胞β-葡萄糖醛酸酶(β-hexosaminidase) 釋放之生物活性。Preferably, the anti-allergy is a biological activity that inhibits the release of cellular β-glucuronidase (β-hexosaminidase).
較佳者,抗氧化為增進細胞自噬作用 (Autophagy) 之細胞活性。Preferably, the antioxidant is a cellular activity that promotes autophagy.
較佳者,抗醣化為抑制細胞衰老相關的β-半乳糖苷酶 (Senescence-associated β-galactosidase) 活化之生物活性。Preferably, anti-glycation is a biological activity that inhibits the activation of cell senescence-associated β-galactosidase.
較佳者,抗皺為抑制玻尿酸酶(Hyaluronidase)分解玻尿酸(Hyaluronan, HA) 活性之生物活性。Preferably, anti-wrinkle is a biological activity that inhibits the decomposition of hyaluronic acid (Hyaluronan, HA) by hyaluronidase.
較佳者,有效劑量為50-500 μg/mL。Preferably, the effective dose is 50-500 μg/mL.
為使本發明上述及/或其他目的、功效、特徵更顯而易懂,令貴審查委員得明瞭本發明之內容,特舉較佳實施方式及實施例分析,詳細說明如下:In order to make the above and/or other objects, effects, and features of the present invention more obvious and understandable, so that the review committee can understand the content of the present invention, the preferred embodiments and examples are analyzed, and the details are as follows:
本發明之一實施方式,為提供一種牡丹萃取物,係以水浸泡牡丹全株萃取而得。One embodiment of the present invention provides a peony extract, which is obtained by soaking the whole peony plant in water.
較佳者,以連續式超音波震盪該水及該牡丹全株。Preferably, the water and the whole peony plant are vibrated with continuous ultrasonic waves.
較佳者,浸泡溫度為 50~80 ˚C。Preferably, the soaking temperature is 50~80 ˚C.
較佳者,浸泡時間為 5~60 分鐘。Preferably, the soaking time is 5 to 60 minutes.
其中,牡丹全株採用毛茛科 (Ranunculaceae) 芍藥屬 (Paeonia) 之牡丹 (Paenoina Suffruticosa)。Among them, the whole peony plant is Paenoina Suffruticosa from the genus Paeonia of the Ranunculaceae family.
較佳者,該牡丹全株包含以下重量份數之原料:牡丹花38~45重量份、牡丹莖葉46~53重量份及牡丹根皮2~9重量份。Preferably, the whole peony plant contains the following raw materials in parts by weight: 38-45 parts by weight of peony flowers, 46-53 parts by weight of peony stems and leaves, and 2-9 parts by weight of peony root bark.
以水浸泡牡丹全株萃取而得之牡丹萃取物,係一牡丹全株水萃萃取物,其具有單萜醣苷類 (glucosides)、黃酮類 (flavonoids) 、單寧 (tannins) 、茋 (stilbenes) 、三萜類化合物 (triterpenoids)、芍藥醇 (paeonols)和酚類 (phenols)等複數種具抗發炎、抗過敏、抗氧化、抗醣化或抗皺之生物活性成分。The peony extract obtained by soaking the whole peony plant in water is an aqueous extract of the whole peony plant, which contains monoterpene glycosides (glucosides), flavonoids (flavonoids), tannins (tannins), and stilbenes (stilbenes). , triterpenoids, paeonols and phenols, and many other bioactive ingredients with anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle properties.
較佳者,牡丹萃取物為減壓濃縮處理或冷凍乾燥處理精製而得的。Preferably, the peony extract is refined by concentration under reduced pressure or freeze-drying.
本發明之另一實施方式提出一種上述牡丹萃取物之製備方法,係包含:以水浸泡牡丹材料萃取而得。Another embodiment of the present invention provides a method for preparing the above-mentioned peony extract, which includes: soaking peony materials in water and extracting the peony extract.
請參閱圖1,例示說明上述牡丹萃取物製備之方法100,但不以此為限。Please refer to Figure 1 to illustrate the method 100 for preparing the above peony extract, but it is not limited thereto.
首先,如步驟101所示,採用牡丹全株,包括牡丹花、牡丹莖葉及牡丹根皮;其中,該牡丹全株包含以下重量份數之原料:牡丹花38~45重量份、牡丹莖葉46~53重量份及牡丹根皮2~9重量份;在一較佳實施例中,牡丹花、牡丹莖葉和牡丹根皮之重量份比例為43:50:7。First, as shown in step 101, the whole peony plant is used, including peony flowers, peony stems and leaves, and peony root bark; wherein, the whole peony plant contains the following raw materials in parts by weight: 38 to 45 parts by weight of peony flowers, peony stems and leaves 46 to 53 parts by weight and 2 to 9 parts by weight of peony root bark; in a preferred embodiment, the weight ratio of peony flowers, peony stems and leaves, and peony root bark is 43:50:7.
接著,如步驟102所示,利用水浸泡,對前述之牡丹全株101進行萃取步驟,以獲得粗萃取物。其中,該牡丹全株與水之重量比例為1:7~1:13;在一較佳實施例中該重量比例為1:10。Next, as shown in step 102, the whole peony plant 101 is soaked in water and subjected to an extraction step to obtain a crude extract. Wherein, the weight ratio of the whole peony plant to water is 1:7~1:13; in a preferred embodiment, the weight ratio is 1:10.
較佳者,以連續式超音波震盪該水及該牡丹全株,在一較佳實施例中超音波功率介於500~800W之間,並以震盪3分鐘後暫停1分鐘之頻率,連續震盪30~60分鐘。Preferably, the water and the whole peony plant are vibrated with continuous ultrasonic waves. In a preferred embodiment, the ultrasonic power is between 500 and 800W. The ultrasonic wave is vibrated for 3 minutes and then paused for 1 minute for 30 consecutive seconds. ~60 minutes.
較佳者,浸泡溫度為 50~80 ˚C。Preferably, the soaking temperature is 50~80 ˚C.
較佳者,浸泡時間為 5~60 分鐘。Preferably, the soaking time is 5 to 60 minutes.
較佳者,浸泡時以加熱輔助達浸泡溫度來進行萃取,在一較佳實施例中以電磁波加熱,電磁波頻率在 300 MHz ~ 300 GHz 之間。Preferably, during soaking, heating is used to assist in reaching the soaking temperature for extraction. In a preferred embodiment, electromagnetic waves are used for heating, and the electromagnetic wave frequency is between 300 MHz and 300 GHz.
在一較佳實施例中,更進一步精製該粗萃取物以取得萃取精緻物:請參見圖1,如步驟103所示,該粗萃取物通過一離心分離處理以獲得一第一萃取液。接著,如步驟104所示,該第一萃取液通過一過濾分離處理以獲得第二萃取液,該過濾分離處理係以一孔徑介於 0.22-0.45 μm之多微孔結構濾膜,利用真空篩檢器過濾該第一萃取液,並去除該第一萃取液所含之細微雜質,以獲得該第二萃取液。最後,如步驟105所示,該第二萃取液經過減壓濃縮機及真空冷凍乾燥機將濾液濃縮並凍乾,以獲得萃取精緻物;該萃取精緻物具備前述牡丹萃取物所包含之複數生物活性成分,經濃縮處理後達到較高濃度,並冷凍乾燥處理後所得之顆粒 (pellet) 更利於製備複數種化妝品組合物及/或食品添加物,其中化妝品組合物可為溶液、懸浮液、膠凍、凝膠、乳液、乳霜、膏劑、粉劑、發泡物、膠囊或清潔用品。In a preferred embodiment, the crude extract is further refined to obtain an extraction refinement: please refer to Figure 1. As shown in step 103, the crude extract is processed through a centrifugal separation to obtain a first extraction liquid. Next, as shown in step 104, the first extraction liquid is subjected to a filtration separation process to obtain a second extraction liquid. The filtration separation process uses a multi-microporous structure filter membrane with a pore size between 0.22-0.45 μm, and uses a vacuum sieve. The detector filters the first extraction liquid and removes fine impurities contained in the first extraction liquid to obtain the second extraction liquid. Finally, as shown in step 105, the second extraction liquid is concentrated and freeze-dried by a decompression concentrator and a vacuum freeze dryer to obtain an extraction product; the extraction product contains the plurality of organisms contained in the aforementioned peony extract. The active ingredients are concentrated to a higher concentration and freeze-dried to obtain pellets, which are more conducive to the preparation of multiple cosmetic compositions and/or food additives. The cosmetic compositions can be solutions, suspensions, and gels. jelly, gel, lotion, cream, ointment, powder, foam, capsule or cleaning product.
在此補充說明的是,本發明所屬技術領域中任何具有通常知識者應可理解,透過微波強化輔助過程可使高頻電磁波穿透萃取介質到達物料內部的微管束和腺胞系統。由於細胞吸收微波能,其內部溫度迅速上升,從而使細胞內部的壓力超過細胞壁膨脹所能承受的能力,進而造成細胞破裂,並釋放出其內的有效成分。以水作溶劑時,在微波場的作用下,水分子由高速轉動狀態轉變為激發態,此時水分子汽化造成萃取組分的驅動力提升,或者釋放出自身多餘的能量而回到基態,所釋放出的能量將傳遞給其他物質的分子,以加速其熱運動,從而縮短萃取組分的分子由固體內部擴散至固液界面的時間,使萃取速率提高數倍,並能降低萃取溫度,並在較低的溫度下溶解於萃取介質中,從而避免萃取組分的分子受到高溫破壞。It should be added here that anyone with ordinary knowledge in the technical field to which the present invention belongs should understand that through the microwave intensification-assisted process, high-frequency electromagnetic waves can penetrate the extraction medium and reach the microtubule bundles and glandular cell systems inside the material. As cells absorb microwave energy, their internal temperature rises rapidly, causing the pressure inside the cells to exceed the capacity of the cell wall to expand, causing the cells to rupture and release the active ingredients within them. When water is used as the solvent, under the action of the microwave field, the water molecules change from a high-speed rotation state to an excited state. At this time, the water molecules vaporize, causing the driving force of the extracted components to increase, or release their excess energy and return to the ground state. The released energy will be transferred to the molecules of other substances to accelerate their thermal motion, thereby shortening the time for the molecules of the extraction components to diffuse from the interior of the solid to the solid-liquid interface, increasing the extraction rate several times, and lowering the extraction temperature. And dissolve in the extraction medium at a lower temperature, thereby preventing the molecules of the extracted components from being damaged by high temperature.
依本發明之牡丹萃取物具有單萜醣苷類(glucosides)、黃酮類(flavonoids)、單寧(tannins)、茋(stilbenes)、三萜類化合物(triterpenoids)、芍藥醇(paeonols)和酚類(phenols)等複數種具抗發炎、抗過敏、抗氧化、抗醣化或抗皺之生物活性成分。基於前述特性,本發明之再一實施方式提出一種牡丹萃取物用於製備抗發炎、抗過敏、抗氧化、抗醣化或抗皺組合物作為美容或食品添加物之用途,係投放一有效劑量至所需個體,以達抗發炎、抗過敏、抗氧化、抗醣化或抗皺之功效。The peony extract according to the present invention has monoterpene glycosides (glucosides), flavonoids (flavonoids), tannins (tannins), stilbenes (stilbenes), triterpenoids (triterpenoids), paeonols (paeonols) and phenols ( phenols) and other bioactive ingredients with anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle properties. Based on the foregoing characteristics, another embodiment of the present invention proposes a peony extract for use in preparing anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle compositions as beauty or food additives, by adding an effective dose to the Individual use is required to achieve anti-inflammatory, anti-allergic, antioxidant, anti-glycation or anti-wrinkle effects.
此處所謂「抗發炎」的生物活性係指前述所得之牡丹萃取物可有效抑制細胞的發炎反應。在本發明一較佳實施例中,前述抑制發炎反應的生物活性可以脂多醣 (Lipopolysaccharide, LPS) 刺激細胞,誘發促炎性細胞因子 IL-1 (Proinflammatory cytokine interleukin-1) 之釋放加以評估。The so-called "anti-inflammatory" biological activity here means that the peony extract obtained above can effectively inhibit the inflammatory response of cells. In a preferred embodiment of the present invention, the aforementioned biological activity of inhibiting inflammatory response can be evaluated by stimulating cells with lipopolysaccharide (LPS) and inducing the release of proinflammatory cytokine interleukin-1 (IL-1).
此處所謂「抗過敏」的生物活性係指前述所得之牡丹萃取物可有效抑制細胞的過敏反應。在本發明一較佳實施例中,前述抑制過敏之生物活性可藉由免疫球蛋白E (IgE) 刺激細胞,誘發去顆粒化 (Degranulation) 所釋放之β-葡萄糖醛酸酶 (β-hexosaminidase) 來加以評估。The so-called "anti-allergic" biological activity here means that the peony extract obtained above can effectively inhibit the allergic reaction of cells. In a preferred embodiment of the present invention, the aforementioned biological activity of inhibiting allergies can be stimulated by immunoglobulin E (IgE) to induce degranulation and release of β-glucuronidase (β-hexosaminidase). to evaluate.
此處所謂「抗氧化」的生物活性係指前述所得之牡丹萃取物可有效提升細胞的抗氧化機制。在本發明一較佳實施例中,前述抗氧化之生物活性可藉由紫外線及氧化壓力刺激細胞,誘發自噬作用 (Autophagy) 當中產生之自噬小體 (Autophagosome) 的數量來加以評估。The so-called "antioxidant" biological activity here means that the peony extract obtained above can effectively enhance the antioxidant mechanism of cells. In a preferred embodiment of the present invention, the aforementioned antioxidant biological activity can be evaluated by stimulating cells with ultraviolet rays and oxidative stress to induce the number of autophagosomes produced during autophagy.
此處所謂「抗醣化」的生物活性係指前述所得之牡丹萃取物可有效抑制細胞的醣化作用。在本發明一較佳實施例中,前述抗醣化之生物活性可藉由紫外線刺激細胞,誘發細胞衰老相關的β-半乳糖苷酶 (Senescence-associated β-galactosidase, SA-β-gal) 之活性來加以評估。The so-called "anti-glycation" biological activity here means that the peony extract obtained above can effectively inhibit the glycation of cells. In a preferred embodiment of the present invention, the aforementioned anti-glycation biological activity can stimulate cells through ultraviolet rays to induce the activity of cell senescence-associated β-galactosidase (SA-β-gal). to evaluate.
此處所謂「抗皺」的生物活性係指前述所得之牡丹萃取物可有效抑制細胞的玻尿酸酶 (Hyaluronidase) 之活性。申言之,玻尿酸為細胞外間質的主要成分,以維持皮膚的含水量、彈性。玻尿酸會被自體生成的酵素所降解,皮膚因此失去了保濕基本功能,並且形成空隙,失去彈力進而鬆弛產生皺紋。在本發明一較佳實施例中,前述抗皺之生物活性可藉由牡丹萃取物抑制玻尿酸酶分解玻尿酸活性之程度來加以評估。The so-called "anti-wrinkle" biological activity here refers to the fact that the peony extract obtained above can effectively inhibit the activity of hyaluronidase in cells. In other words, hyaluronic acid is the main component of the extracellular matrix to maintain the moisture content and elasticity of the skin. Hyaluronic acid will be degraded by self-generated enzymes. As a result, the skin loses its basic function of moisturizing, forms gaps, loses elasticity, and relaxes, causing wrinkles. In a preferred embodiment of the present invention, the aforementioned anti-wrinkle biological activity can be evaluated by the extent to which the peony extract inhibits the activity of hyaluronidase to decompose hyaluronic acid.
較佳者,有效劑量為 50-500 μg/mL。Preferably, the effective dose is 50-500 μg/mL.
以下通過實施例說明該牡丹萃取物之製備,並評估該牡丹萃取物之抗發炎、抗過敏、抗氧化、抗醣化或抗皺等生物活性。The following examples illustrate the preparation of the peony extract, and evaluate the biological activities of the peony extract such as anti-inflammation, anti-allergy, antioxidant, anti-glycation or anti-wrinkle.
實施例一:製備牡丹萃取物Example 1: Preparation of Peony Extract
採用牡丹全株,包括牡丹花、牡丹莖葉和牡丹根皮,其中牡丹花、牡丹莖葉和牡丹根皮之重量份比例為 43:50:7;以水浸泡牡丹全株,先以功率500~800W之超音波震盪該水及該牡丹全株,並以震盪3分鐘後暫停1分鐘之頻率,連續震盪 30~60 分鐘,再以微波加熱至 50~80˚C 並浸泡 5~60 分鐘 ,以獲得粗萃取物,其中牡丹全株與水之重量比例為 1:10。Use the whole peony plant, including peony flowers, peony stems and leaves, and peony root bark. The weight ratio of peony flowers, peony stems and leaves, and peony root bark is 43:50:7; soak the whole peony plant in water, and first use the power 500 The water and the whole peony plant were vibrated with ~800W ultrasonic waves, and the vibration was continued for 30~60 minutes at a frequency of 3 minutes followed by a 1 minute pause, and then heated to 50~80˚C by microwave and soaked for 5~60 minutes. To obtain a crude extract, the weight ratio of the whole peony plant to water is 1:10.
接著,更進一步精製該粗萃取物以取得萃取精緻物:該粗萃取物通過一離心分離處理 (-20°C / 15,000 g / 10 分鐘) 去除底部沈澱物,獲得第一萃取液。該第一萃取液通過一過濾分離處理,為孔徑介於 0.22-0.45 μm 之多微孔結構濾膜,經真空篩檢器過濾並去除第一萃取液所含之細微雜質,獲得該第二萃取液。最後,該第二萃取液經過減壓濃縮機及真空冷凍乾燥機將濾液濃縮並凍乾,以獲得萃取精緻物。Then, the crude extract is further refined to obtain the refined product: the crude extract is subjected to a centrifugal separation process (-20°C/15,000 g/10 minutes) to remove the bottom sediment to obtain the first extract. The first extraction liquid is separated by filtration and becomes a multi-microporous structure filter membrane with a pore size between 0.22-0.45 μm. It is filtered through a vacuum screen to remove the fine impurities contained in the first extraction liquid, and the second extraction liquid is obtained. liquid. Finally, the second extract is passed through a vacuum concentrator and a vacuum freeze dryer to concentrate the filtrate and freeze-dry it to obtain the refined extract.
實施例二:評估牡丹萃取物抗發炎之應用。Example 2: Evaluation of the anti-inflammatory application of peony extract.
測試牡丹萃取物是否抑制人類皮膚角質株化細胞 (HaCaT) 促炎性細胞因子 IL-1 之釋放,以達抗發炎之功效。將前述 HaCaT 細胞以細胞培養液打散,並以 3 × 10
5/mL 之細胞數於 24-well 多孔細胞培養盤中培養,置於在37 ºC 及 5% CO
2培養箱中培養 24 小時。於細胞培養液加入該牡丹萃取物反應30 分鐘後,再加入 1 μg/mL 脂多糖 (Lipopolysaccharide, LPS) 反應。達反應時間後,收集細胞培養液,以1200 rpm 離心 5 分鐘,並取上清液至滅菌處理之 1.5 mL離心管於 -20 °C 冷凍保存。
表1
使用 BD OptEIA TMSet 進行上清液中 IL-1 含量測定:於 96-well 微量多孔盤盤底塗布捕獲抗體 (capture Ab),在每個盤孔中加入 100 μL 稀釋之捕獲抗體,其中捕獲抗體之稀釋倍數為 250 倍,再以保鮮膜密封盤子後,放置於4 ºC 至隔夜。以洗滌液 (wash buffer, PBST) 清洗前述 96-well 微量多孔盤 3 次。接著,於每個盤孔加入 200 μL assay diluent ,並在室溫下反應 1 小時後,重複前述之清洗的步驟。加入 100 μL 細胞上清液,以保鮮膜密封盤子後,於室溫下反應 2 小時,之後以洗滌液 (PBST) 清洗 5 次。加入 100 μL 操作檢測液 (working detector) ,密封盤子後於室溫下反應1小時後,以洗滌液 (PBST) 清洗7次。此處使用之操作檢測液 (working detector) 係 500 倍稀釋之檢測抗體混合 250 倍稀釋之酵素試劑。最後,加入 50 μL 基質液 (substrate solution) 室溫下反應 30 分鐘後,加入 50 μL 的終止液 (stop solution: 1M H 3PO 4或 2N H 2SO 4),測定 450 nm 之吸光值 (BioTek, Synergy TM2, USA)。 Use the BD OptEIA TM Set to measure the IL-1 content in the supernatant: Coat the bottom of a 96-well micro-porous plate with capture antibody (capture Ab), and add 100 μL of diluted capture antibody to each plate well, where the capture antibody The dilution factor is 250 times, then seal the plate with plastic wrap and place it at 4 ºC overnight. Wash the aforementioned 96-well microporous plate three times with wash buffer (PBST). Then, add 200 μL assay diluent to each plate well and react at room temperature for 1 hour. Repeat the aforementioned cleaning steps. Add 100 μL of cell supernatant, seal the plate with plastic wrap, react at room temperature for 2 hours, and then wash 5 times with washing solution (PBST). Add 100 μL working detector, seal the plate and react at room temperature for 1 hour, then wash 7 times with PBST. The working detector used here is a 500-fold diluted detection antibody mixed with a 250-fold diluted enzyme reagent. Finally, add 50 μL of substrate solution and react at room temperature for 30 minutes, then add 50 μL of stop solution (stop solution: 1M H 3 PO 4 or 2N H 2 SO 4 ), and measure the absorbance value at 450 nm (BioTek , Synergy TM 2, USA).
此實施例中,以細胞培養液添加 LPS 但未添加該牡丹萃取物作為正控制組;未添加 LPS 為負控制組,其細胞上清液中所測得之 IL-1 含量定義為 1.0。請參見表1,經過 LPS 作用後,正控制組細胞上清液中 IL-1 含量為 3.7,而經牡丹萃取物 (50、100、500 μg/mL) 作用後,細胞上清液中 IL-1 含量分別為 1.9、1.6 和 1.2,結果顯示牡丹萃取物具有抑制細胞促發炎因子 IL-1 釋放,降低細胞發炎反應之能力。
表2
實施例三:評估牡丹萃取物抗敏之應用Example 3: Evaluating the anti-allergic application of peony extract
本次實驗藉由測量肥大細胞 (RBL-2H3) 經 IgE 刺激後,所釋放β-葡萄糖醛酸酶的量,用以評估牡丹萃取物是否具備有抑制過敏反應之功效。將前述肥大細胞以 2×10 4cells/well 之細胞密度,以 10% FBS/DMEM 之培養液培養於 96-well 多孔細胞培養盤中。於 0.5% FBS 之 DMEM 細胞培養液中,以牡丹萃取物預處理 24 小時。接著,加入 anti-DNP IgE Ab (1 μg/mL)後培養 6-12 小時。洗滌掉前述含有 anti-DNP IgE Ab 之細胞培養液,再加入 DNP-BSA (100 ng/mL) 並培養 1 小時以活化肥大細胞,接著收集細胞上清液並冷凍保存。於另一 96-well 微量多孔盤中加入細胞上清液與 p-NAG 受質 (1 μM),其體積比例為1:1,並於 37°C 培養1小時後,測量 405 nm 之吸光值 (BioTek, Synergy TM2, USA)。 This experiment measured the amount of β-glucuronidase released by mast cells (RBL-2H3) after IgE stimulation to evaluate whether peony extract has the effect of inhibiting allergic reactions. The aforementioned mast cells were cultured in a 96-well multi-well cell culture dish at a cell density of 2×10 4 cells/well in 10% FBS/DMEM culture medium. The cells were pretreated with peony extract in DMEM cell culture medium with 0.5% FBS for 24 hours. Next, anti-DNP IgE Ab (1 μg/mL) was added and incubated for 6-12 hours. Wash away the aforementioned cell culture medium containing anti-DNP IgE Ab, add DNP-BSA (100 ng/mL) and incubate for 1 hour to activate mast cells, then collect the cell supernatant and freeze it for storage. Add cell supernatant and p-NAG substrate (1 μM) to another 96-well micro-well plate at a volume ratio of 1:1, and incubate at 37°C for 1 hour. Then measure the absorbance at 405 nm. (BioTek, Synergy ™ 2, USA).
此實施例以卡西霉素 A23187 (1 µM) 進行誘導過敏反應作為正控制組,其抑制β-葡萄糖醛酸酶抑制率定義為 0.0%;以未處理之細胞作為負控制組,其β-葡萄糖醛酸酶抑制率定義為 100%。請參見表2,經該牡丹萃取物(50、100、500 μg/mL)作用後的肥大細胞,其β-葡萄糖醛酸酶抑制率下降至 4.8%、21.2% 及 48.4%,結果顯示該牡丹萃取物具抑制β-葡萄糖醛酸酶釋放,降低由IgE引發之細胞過敏反應的能力。
表3
實施例四:評估牡丹萃取物抗氧化之應用。Example 4: Evaluation of the antioxidant application of peony extract.
利用測試人類皮膚角質株化細胞(HaCaT)內自噬小體(Autophagosome) 之數量變化作為細胞自噬作用之量化標準,用以評估該牡丹萃取物是否提升細胞自噬作用,以達提升抗紫外線及氧化壓力之功效。前述人類 HaCaT 細胞以 1.5×10 5cell/mL 之細胞密度培養於 96-well 多孔細胞培養盤中,並在 37˚C、5% CO 2培養箱中生長 24 小時以上,再加入該牡丹萃取物反應。達反應時間後,移除細胞培養液,以PBS清洗。以劑量 20 mJ/cm 2之 UVB 照射細胞,誘發細胞自噬作用,再加入含有 0.1mM H 2O 2之新鮮培養液,並作用 1 小時。加入Autophagosome detection reagent working solution,置於培養箱反應 15 分鐘至 1 小時後,再以洗滌液 (PBST) 清洗細胞。加入定量 PBS,於 Excitation: 360 nm/Emission: 550 nm 之設定下測定吸光值 (BioTek, Synergy TM2, USA)。 The quantitative change of autophagosomes in human skin keratinocytes (HaCaT) is used as a quantitative standard for autophagy to evaluate whether the peony extract can enhance autophagy to improve UV resistance. and oxidative stress effects. The aforementioned human HaCaT cells were cultured in a 96-well multi-well cell culture plate at a cell density of 1.5×10 5 cell/mL, and grown in a 37˚C, 5% CO 2 incubator for more than 24 hours, and then the peony extract was added reaction. After the reaction time is reached, remove the cell culture medium and wash with PBS. The cells were irradiated with UVB at a dose of 20 mJ/cm 2 to induce autophagy, and then fresh culture medium containing 0.1mM H 2 O 2 was added and allowed to act for 1 hour. Add Autophagosome detection reagent working solution, place in the incubator to react for 15 minutes to 1 hour, and then wash the cells with washing solution (PBST). Add quantitative PBS and measure the absorbance value (BioTek, Synergy TM 2, USA) at the setting of Excitation: 360 nm/Emission: 550 nm.
此實施例以未經過紫外線和 H 2O 2作用之 HaCaT 細胞作為控制組,其自噬作用定義為 100%。請參見表3,在 UVB 和 H 2O 2作用下,HaCaT 細胞的自噬作用增加至 105.5%,經牡丹萃取物 (50、100和500 μg/mL) 作用後,HaCaT 細胞之自噬作用增加至 107.5%、112.2% 和 116.7%,結果顯示該牡丹萃取物具促進細胞之自噬作用,增進細胞排除自由基及對抗紫外線的能力。 In this example, HaCaT cells that have not been exposed to ultraviolet light and H 2 O 2 are used as the control group, and their autophagy is defined as 100%. Please see Table 3. Under the action of UVB and H 2 O 2 , the autophagy of HaCaT cells increased to 105.5%. After the action of peony extract (50, 100 and 500 μg/mL), the autophagy of HaCaT cells increased. to 107.5%, 112.2% and 116.7%. The results show that the peony extract can promote the autophagy of cells, enhance the ability of cells to eliminate free radicals and resist ultraviolet rays.
實施例五:評估牡丹萃取物抗醣化之應用Example 5: Evaluating the application of peony extract against glycation
利用測試人類皮膚角質株化細胞 (HaCaT) 或人類皮膚纖維母細胞 (Hs68) 之衰老相關的β-半乳糖苷酶 (Senescence-associated β-galactosidase, SA-β-gal) 活性,來評估該牡丹萃取物是否具備抑制皮膚細胞中SA-β-gal活性之能力,以達到抗醣化、抗衰老之功效。將前述 HaCaT 細胞和 Hs68 細胞分別以1 × 10 5/mL 之細胞密度培養於 24-well 多孔細胞培養盤中,並培養24小時等待細胞貼附。於置換新鮮培養液後,加入該牡丹萃取物並處理24小時。接著,使用劑量 50 mJ/cm 2之UVB照射細胞。接著,以不含血清之培養液置換原培養液,並培養24小時。達反應時間後,使用 senescence β-galactosidase staining kit (Cell Signaling Technology, Danvers, MA, USA) 進行染色,並利用顯微鏡觀察且計數老化細胞,其老化細胞於染劑作用下呈現藍色。 The peony was evaluated by testing the senescence-associated β-galactosidase (SA-β-gal) activity in human skin keratinocytes (HaCaT) or human skin fibroblasts (Hs68). Whether the extract has the ability to inhibit SA-β-gal activity in skin cells to achieve anti-glycation and anti-aging effects. The aforementioned HaCaT cells and Hs68 cells were cultured in a 24-well multi-well cell culture dish at a cell density of 1 × 10 5 /mL, and cultured for 24 hours to wait for cell attachment. After replacing the fresh culture medium, the peony extract was added and treated for 24 hours. Next, the cells were irradiated with UVB at a dose of 50 mJ/ cm2 . Then, the original culture medium was replaced with serum-free culture medium and cultured for 24 hours. After the reaction time has elapsed, senescence β-galactosidase staining kit (Cell Signaling Technology, Danvers, MA, USA) was used for staining, and aged cells were observed and counted under a microscope. The aged cells appeared blue under the action of the dye.
此實施例以未處置之 HaCaT 細胞和 Hs68 細胞作為控制組,其細胞內 SA-β-gal 之活性定義為 100%。請參見表4,經 UVB 照射後,細胞中 SA-β-gal 之活性上升至 456.3%。經牡丹萃取物 (50、100和500 μg/mL) 處置後,SA-β-gal 之活性分別下降至 392.7%、325.1% 及 276.5%,結果顯示該牡丹萃取物能抑制UVB誘導活化之 SA-β-gal 之活性,減少細胞的醣化作用。
表4
實施例六:評估牡丹萃取物抑制玻尿酸酶活性之應用。Example 6: Evaluation of the application of peony extract in inhibiting hyaluronidase activity.
在此實施例中,利用蛋白質膠體電泳 (SDS-PAGE) 實驗方法測試純化之玻尿酸酶活性是否受到牡丹萃取物來評估其抗老化之功效,其原理為:製膠過程中加入玻尿酸 (Hyaluronan, HA),由該牡丹萃取物與玻尿酸酶 (hyaluronidase, HAase) 反應後,依序滴入膠片中,進行 SDS-PAGE。完成後,取下膠片以溶於 3% 醋酸溶液之艾爾遜藍染色劑 (alcian blue stain) 染色,觀察牡丹萃取物是否抑制 HAase 的活性。若深藍色膠片背景中,有透明條帶明顯呈現,表示牡丹萃取物無法抑制 HAase 活性;反之,若深藍色膠片顏色保持不變,則表示牡丹萃取物成功抑制 HAase 之活性。其中,本實施例測試 HAase 之濃度為 3000 units/mL。In this example, the protein colloidal electrophoresis (SDS-PAGE) experimental method was used to test whether the purified hyaluronidase activity is affected by peony extract to evaluate its anti-aging effect. The principle is: hyaluronic acid (Hyaluronan, HA) is added during the gel making process. ), after reacting the peony extract with hyaluronidase (HAase), it was sequentially dropped into the film for SDS-PAGE. After completion, remove the film and stain it with alcian blue stain dissolved in 3% acetic acid solution to observe whether the peony extract inhibits HAase activity. If a transparent band appears clearly in the dark blue film background, it means that the peony extract cannot inhibit HAase activity; conversely, if the color of the dark blue film remains unchanged, it means that the peony extract successfully inhibits HAase activity. Among them, the concentration of HAase tested in this example is 3000 units/mL.
(1) 製備本試驗待測樣品:沒食子兒茶酸 (epigallocatechin gallate, EGCG) 對於 HAase 活性具抑制能力為本領域所公知,以 4 μL 濃度 100ug/ml 之 EGCG 混合 2 μL 稀釋 200X 之 HAase 製備為正控制組樣本;以 11.5 μL 0.15M氯化鈉-甲酸鈉緩衝液(NaCl-sodium formate buffer, pH5.7)混合 2 μL 稀釋 200X 之 HAase 製備為負控制組;以11.5 μL 25 mg/mL之牡丹萃取物混合 2 μL 稀釋 200X 之 HAase 製備為實驗組。接著,將待測樣品包含正、負控制組及實驗組在混合均勻後,分別置入恆溫水浴槽,並以 37°C 反應 18 小時。(1) Prepare the sample to be tested in this test: epigallocatechin gallate (EGCG) is known in the art to have the ability to inhibit HAase activity. Mix 4 μL of EGCG with a concentration of 100ug/ml and 2 μL of HAase diluted 200X. Prepare a positive control group sample; mix 11.5 μL 0.15M sodium chloride-sodium formate buffer (NaCl-sodium formate buffer, pH5.7) with 2 μL diluted 200X HAase to prepare a negative control group; use 11.5 μL 25 mg/mL The peony extract was mixed with 2 μL of HAase diluted 200X to prepare the experimental group. Then, the samples to be tested, including the positive and negative control groups and the experimental group, were mixed evenly, placed in a constant temperature water bath, and reacted at 37°C for 18 hours.
(2) 製作SDS-聚丙烯醯胺膠片 (SDS-polyacrylamide gels):SDS-聚丙烯醯胺膠片包括分離膠體 (running gel) 及焦集膠體 (stacking gel),其中分離膠體以 10% (v/v) 之聚丙烯醯胺配製並添加 1.7mL 之 0.1% 玻尿酸;焦集膠體以5% (v/v) 之聚丙烯醯胺配製。待測樣品於反應 18 小時後,各與 4.5 μL 之四倍電泳指示劑 (4X loading dye) 均勻混合,靜置於室溫下。配製蛋白質標記 (Mid-Range Protein Marker, GM47, GeneMark) 做為對照組,以 4 μL 蛋白質標記混合 4 μL 之兩倍電泳指示劑後,於 100 °C 沸水加熱 10 分鐘,靜置於室溫下。(2) Make SDS-polyacrylamide gels: SDS-polyacrylamide gels include running gel and stacking gel, of which the separating colloid is 10% (v/ v) Polyacrylamide and add 1.7mL of 0.1% hyaluronic acid; the focal gel is formulated with 5% (v/v) polyacrylamide. After reacting for 18 hours, the samples to be tested were evenly mixed with 4.5 μL of four-fold electrophoresis indicator (4X loading dye) and allowed to stand at room temperature. Prepare a protein marker (Mid-Range Protein Marker, GM47, GeneMark) as a control group. Mix 4 μL of protein marker with 4 μL of twice the electrophoresis indicator, heat it in boiling water at 100 °C for 10 minutes, and let it stand at room temperature. .
(3) 電泳分析待測樣品:架設SDS-聚丙烯醯胺膠片於蛋白質電泳槽上,並將對照組及待測樣品包括正控制組、負控制組及實驗組依序注入焦集膠體之小孔中,再注入適量的電泳緩衝液 (running buffer) 至蛋白質電泳槽中,並設定電壓 80 伏特作用 3 小時後,自蛋白質電泳槽取下分離膠體膠片,以 HEPES (pH7.4) 緩衝液清洗分離膠體膠片三次,每次在室溫中溫和搖盪 10 分鐘。(3) Electrophoresis analysis of the sample to be tested: Set up the SDS-polyacrylamide film on the protein electrophoresis tank, and inject the control group and the sample to be tested, including the positive control group, negative control group and experimental group, into a small amount of focus colloid in sequence. into the well, then inject an appropriate amount of running buffer into the protein electrophoresis tank, and set the voltage to 80 volts. After 3 hours, remove the separation colloid film from the protein electrophoresis tank and wash it with HEPES (pH7.4) buffer. Separate the colloidal film three times, each time with gentle shaking at room temperature for 10 minutes.
(4) 染色分析分離膠體膠片:以氯化鈉-甲酸鈉緩衝液 (0.15M NaCl-0.1M sodium formate, pH5.7) 浸泡分離膠體膠片,並置入恆溫水浴槽,於 37 °C反應 18 小時;於艾爾遜藍染色液中搖盪分離膠體膠片 20 分鐘,再以考馬斯亮藍 R-250 (Coomassie brilliant blue R-250) 染色 30 分鐘後,退染並拍攝分離膠體膠片影像,再利用 Image J 進行影像量化分析並判讀結果。(4) Dyeing analysis and separation of colloid film: Soak the separation colloid film in sodium chloride-sodium formate buffer (0.15M NaCl-0.1M sodium formate, pH5.7), place it in a constant temperature water bath, and react at 37 °C for 18 hours. ; Shake the separation colloid film in Airson's blue staining solution for 20 minutes, then stain it with Coomassie brilliant blue R-250 for 30 minutes, destain and photograph the separation colloid film image, and then use Image J Perform quantitative image analysis and interpret results.
請參見圖2A,此處呈現分離膠體膠片染色之影像,正控制組受艾爾遜藍染色劑染色呈現藍色,顯示其玻尿酸未受玻尿酸酶降解,蓋因 EGCG 抑制 HAase 之活性;負控制組未受艾爾遜藍染色劑染色而呈透明,顯示其玻尿酸已受玻尿酸酶降解;實驗組則受艾爾遜藍染色劑染色呈現藍色,顯示其玻尿酸未受玻尿酸酶降解。請參見圖2B,經染色之影像量化分析後,定義負控制組之玻尿酸酶活性抑制為 0.0%,換算牡丹萃取物可抑制玻尿酸酶活性達 59.0%,結果顯示該牡丹萃取物能有效抑制玻尿酸酶活性。Please refer to Figure 2A, which shows the image of the staining of the separated colloid film. The positive control group was stained blue with Elson's blue stain, showing that its hyaluronic acid was not degraded by hyaluronidase because EGCG inhibited the activity of HAase; the negative control group The ones in the experimental group that were not stained by Airson's blue stain were transparent, indicating that the hyaluronic acid had been degraded by hyaluronidase; the experimental group was stained by Airson's blue dye and appeared blue, indicating that the hyaluronic acid had not been degraded by hyaluronidase. Please refer to Figure 2B. After quantitative analysis of stained images, the inhibition of hyaluronidase activity in the negative control group was defined as 0.0%. The peony extract can inhibit hyaluronidase activity by 59.0%. The results show that the peony extract can effectively inhibit hyaluronidase. active.
藉由上述之實施例說明可進一步結論,本發明與現有技術相較之下,本發明具有以下優點:It can be further concluded from the above embodiments that compared with the prior art, the present invention has the following advantages:
1. 本發明之牡丹萃取物,透過抑制細胞促發炎因子IL-1,以達到促進細胞抗發炎之功效。1. The peony extract of the present invention achieves the effect of promoting anti-inflammatory effects of cells by inhibiting the pro-inflammatory factor IL-1 in cells.
2. 本發明之牡丹萃取物,通過抑制β-葡萄糖醛酸酶之釋放,降低免疫球蛋白IgE刺激細胞的過敏反應,以達到抗過敏之功效。2. The peony extract of the present invention reduces the allergic reaction of cells stimulated by immunoglobulin IgE by inhibiting the release of β-glucuronidase, thereby achieving anti-allergic effects.
3. 本發明之牡丹萃取物,能有效的增進細胞自噬作用排除過多自由基,以達到抗紫外線及氧化壓力之功效。3. The peony extract of the present invention can effectively promote cell autophagy and eliminate excessive free radicals, so as to achieve the effect of resisting ultraviolet rays and oxidative stress.
4. 本發明之牡丹萃取物,具備有效抑制紫外線活化之衰老相關的β-半乳糖苷酶之活性,以達到抗紫外線及抗醣化之功效。4. The peony extract of the present invention has the activity of effectively inhibiting the aging-related β-galactosidase activated by ultraviolet rays, so as to achieve the effects of anti-ultraviolet rays and anti-glycation.
5. 本發明之牡丹萃取物,能抑制玻尿酸酶之活性,以達減緩玻尿酸降解流失、提升保濕抗皺之功效。5. The peony extract of the present invention can inhibit the activity of hyaluronidase, thereby slowing down the degradation and loss of hyaluronic acid and improving moisturizing and anti-wrinkle effects.
本發明雖揭露數個實施例如上,然其並非用以限定本發明。在本發明所屬技術領域中,任何具有通常知識者可在不脫本發明之精神與範圍內,作各種更動與潤飾。故此,本發明之保護範圍當視列舉之申請專利範圍所界定者為準。Although the present invention discloses several embodiments as above, they are not intended to limit the present invention. Anyone with ordinary knowledge in the technical field to which the present invention belongs can make various modifications and modifications without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention shall be determined by the listed patent application scope.
100:方法 101:提供牡丹全株 102:水浸泡牡丹全株,以連續式超音波微波萃取方式,取得粗萃取物 103:對粗萃取物進行離心分離處理,以獲得第一萃取液 104:對第一萃取液進行一過濾分離處理,以獲得第二萃取液 105:以減壓濃縮及冷凍乾燥濃縮乾燥第二萃取液,以獲得萃取精緻物 100:Method 101: Provide whole peony plant 102: Soak the whole peony plant in water and obtain the crude extract using continuous ultrasonic and microwave extraction. 103: Centrifuge the crude extract to obtain the first extraction liquid 104: Perform a filtration and separation process on the first extraction liquid to obtain the second extraction liquid 105: Concentrate and dry the second extract under reduced pressure to obtain the refined extract.
圖1係牡丹萃取技術流程圖; 圖2A係顯示實施例六之牡丹萃取物抑制玻尿酸酶活性之蛋白質膠體電泳圖; 圖2B係顯示實施例六之牡丹萃取物抑制玻尿酸酶活性之直方圖。 Figure 1 is a flow chart of peony extraction technology; Figure 2A is a protein colloid electrophoresis pattern showing the inhibition of hyaluronidase activity by the peony extract of Example 6; Figure 2B is a histogram showing the inhibition of hyaluronidase activity by the peony extract of Example 6.
100:方法 100:Method
101:提供牡丹全株 101: Provide whole peony plant
102:水浸泡牡丹全株,以連續式超音波微波萃取方式,取得粗萃取物 102: Soak the whole peony plant in water and obtain the crude extract using continuous ultrasonic and microwave extraction.
103:對粗萃取物進行離心分離處理,以獲得第一萃取液 103: Centrifuge the crude extract to obtain the first extraction liquid
104:對第一萃取液進行一過濾分離處理,以獲得第二萃取液 104: Perform a filtration and separation process on the first extraction liquid to obtain the second extraction liquid
105:以減壓濃縮及冷凍乾燥濃縮乾燥第二萃取液,以獲得萃取精緻物 105: Concentrate and dry the second extract under reduced pressure to obtain the refined extract.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110100913A TWI818223B (en) | 2021-01-11 | 2021-01-11 | Peony extract for anti-inflammation, anti-allergy, anti-oxidation, anti-glycation and anti-wrinkle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110100913A TWI818223B (en) | 2021-01-11 | 2021-01-11 | Peony extract for anti-inflammation, anti-allergy, anti-oxidation, anti-glycation and anti-wrinkle |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202227116A TW202227116A (en) | 2022-07-16 |
TWI818223B true TWI818223B (en) | 2023-10-11 |
Family
ID=83436834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110100913A TWI818223B (en) | 2021-01-11 | 2021-01-11 | Peony extract for anti-inflammation, anti-allergy, anti-oxidation, anti-glycation and anti-wrinkle |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI818223B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116492256A (en) * | 2023-05-05 | 2023-07-28 | 国珍健康科技(北京)有限公司 | Paeonia ostii extract and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110731933A (en) * | 2019-11-25 | 2020-01-31 | 肤能生物科技(洛阳)有限公司 | allergy-relieving, moisturizing and anti-aging hand cream containing peony whole plant extract and preparation method thereof |
CN111616999A (en) * | 2020-06-15 | 2020-09-04 | 西北农林科技大学 | Preparation method of peony soothing and anti-allergy essence and essence |
CN111658583A (en) * | 2020-06-15 | 2020-09-15 | 西北农林科技大学 | Preparation method of peony moistening anti-inflammatory essence and essence |
-
2021
- 2021-01-11 TW TW110100913A patent/TWI818223B/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110731933A (en) * | 2019-11-25 | 2020-01-31 | 肤能生物科技(洛阳)有限公司 | allergy-relieving, moisturizing and anti-aging hand cream containing peony whole plant extract and preparation method thereof |
CN111616999A (en) * | 2020-06-15 | 2020-09-04 | 西北农林科技大学 | Preparation method of peony soothing and anti-allergy essence and essence |
CN111658583A (en) * | 2020-06-15 | 2020-09-15 | 西北农林科技大学 | Preparation method of peony moistening anti-inflammatory essence and essence |
Non-Patent Citations (3)
Title |
---|
;期刊 Li, Chengcheng, et al. "Effects of different extraction methods on yield, purity, composition, antioxidant and antimicrobial activities of phenolics from peony flowers." Journal of Food Measurement and Characterization 14.2 (2020): 716-724. * |
期刊 He, Jingyu, et al. "Comparison of chemical compositions, antioxidant, and anti-photoaging activities of Paeonia suffruticosa flowers at different flowering stages." Antioxidants 8 .9 (2019): 345.;期刊 Ha, Do Thi, et al. "Inhibitors of aldose reductase and formation of advanced glycation end-products in Moutan Cortex (Paeonia suffruticosa)." Journal of natural products 72.8 (2009): . 1465-1470;網路文獻 牡丹產業技術創新用超聲微波組合法從牡丹皮中提取丹皮酚, 牡丹晚報, 2018.10.15 * |
期刊 Li, Chengcheng, et al. "Effects of different extraction methods on yield, purity, composition, antioxidant and antimicrobial activities of phenolics from peony flowers." Journal of Food Measurement and Characterization 14.2 (2020): 716-724. |
Also Published As
Publication number | Publication date |
---|---|
TW202227116A (en) | 2022-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101716680B1 (en) | Shiunko fermented oil and producing method thereof | |
CN109152724A (en) | The collaboration extract of dulse and jasmine, composition comprising the collaboration extract and application thereof | |
Trabelsi et al. | Purification, composition and biological activities of a novel heteropolysaccharide extracted from Linum usitatissimum L. seeds on laser burn wound | |
CN107809998A (en) | Hydroalcoholic extract of mastic from the animal of the genus mastic, cosmetic composition containing it and cosmetic use thereof | |
TWI818223B (en) | Peony extract for anti-inflammation, anti-allergy, anti-oxidation, anti-glycation and anti-wrinkle | |
KR20160091300A (en) | Use of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging | |
CN111419760A (en) | Fresh black tiger leaf extracting solution and preparation method and application thereof | |
CN105496842B (en) | A kind of preparation method and antioxidation of Herba Cistanches bulb extract | |
CN117298023A (en) | Method for extracting polyphenol in dendrobium flowers by combining supermolecular freezing and ultrasonic | |
TWI790760B (en) | Use of caulerpa lentillifera extract for making a composition promoting anti-inflammation, anti-oxidation and anti-cancer of skin | |
KR101813871B1 (en) | Cosmetic composition containing complex medicinal herbs extract for skin whitening and anti-wrinkle effect and manufacturing method thereof | |
CN113350231B (en) | Use of agalloch eaglewood seed extract for preparing skin repair composition | |
CN116019742A (en) | Peony extract for anti-inflammatory, anti-allergic, antioxidant, anti-glycosylated and anti-wrinkle use | |
KR102283047B1 (en) | An ethanol extract composition of Citrus Unshiu Peel, Magnolia Bark, Corydalis and Gambir with improved skin wrinkles, moisturizing, antioxidant and anti-inflammatory effects | |
CN109453104A (en) | Light spot skin toner Essence and its preparation process | |
TWI837515B (en) | Use of caulerpa lentillifera extract for making caulerpa lentillifera composition slowing down collagen egradation and promoting collagen synthesis of skin | |
KR102337454B1 (en) | Cosmetic Composition for Protecting Skin against Particulate Matter | |
TWI855443B (en) | Fagopyrum seed extract for cell protection, cell growth promotion, anti-oxidation and anti-inflammation | |
CN116422002B (en) | Aloe extract and preparation method and application thereof | |
TWI726634B (en) | Extracting method for cyphomandra betacea sendt and composition thereof | |
TWI838291B (en) | Use of extract of pilea microphylla for manufacturing anti-inflammatory preparations | |
CN114272195B (en) | Composition for resisting ultraviolet and blue light damage, and preparation method and application thereof | |
WO2024050647A1 (en) | Extraction system and method | |
CN117695176A (en) | Process for preparing tremella extract by fermentation method and composition containing tremella extract | |
CN116421512A (en) | Essential oil formula and preparation method thereof |